TWI818754B - Mixer for injection medicines - Google Patents
Mixer for injection medicines Download PDFInfo
- Publication number
- TWI818754B TWI818754B TW111137450A TW111137450A TWI818754B TW I818754 B TWI818754 B TW I818754B TW 111137450 A TW111137450 A TW 111137450A TW 111137450 A TW111137450 A TW 111137450A TW I818754 B TWI818754 B TW I818754B
- Authority
- TW
- Taiwan
- Prior art keywords
- injection
- box
- motor
- connecting rod
- fixed
- Prior art date
Links
- 238000002347 injection Methods 0.000 title claims abstract description 27
- 239000007924 injection Substances 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 238000010586 diagram Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- LITBAYYWXZOHAW-XDZRHBBOSA-N (2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]hept Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 LITBAYYWXZOHAW-XDZRHBBOSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 108010010056 Terlipressin Proteins 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- BENFXAYNYRLAIU-QSVFAHTRSA-N terlipressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC1 BENFXAYNYRLAIU-QSVFAHTRSA-N 0.000 description 1
- 229960003813 terlipressin Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Accessories For Mixers (AREA)
- Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
Abstract
Description
本發明係有關於一種混合器,尤指一種針劑藥物之混合器。 The present invention relates to a mixer, in particular to a mixer for injection drugs.
臨床外科病患經常需要使用抗生素治療,特別是外科手術或傷口治療,抗生素為可殺死或是預防細菌滋長的藥物,其使用途徑包含口服、靜脈注射或是直接經由皮膚擦拭吸收。抗生素被視為可預防手術部位感染,故常應用於術後傷口照護上。 Clinical surgical patients often need to be treated with antibiotics, especially during surgery or wound treatment. Antibiotics are drugs that can kill or prevent the growth of bacteria. They are administered orally, intravenously, or absorbed directly through skin wiping. Antibiotics are considered to prevent surgical site infections and are often used in postoperative wound care.
在臨床照護病患的經驗中,許多病患不單只使用一種抗生素,給藥的途徑可能也不只一種,常見的粉狀抗生素(粉狀抗生素有Piperacillin tazobactam、piperacillin、Ampicillin、Terlipressin等)經由靜脈注射後能有效進入血液循環,達到有效治療、抑菌的作用。然而臨床護理人員在給藥稀釋抗生素的過程中經常花費許多時間,也因部分粉狀抗生素稀釋、溶解藥物的時間較長,或不容易溶解,此類藥物稀釋、混合後常常凝結成塊狀,需要搖晃較長時間才能溶解完全,造成延長給藥時間,增加護理人員等待完全混合溶解的時間。 In the clinical experience of caring for patients, many patients not only use one kind of antibiotics, but also may have more than one route of administration. Common powdered antibiotics (powdered antibiotics include Piperacillin tazobactam, piperacillin, Ampicillin, Terlipressin, etc.) are injected intravenously. It can then effectively enter the blood circulation to achieve effective therapeutic and antibacterial effects. However, clinical nurses often spend a lot of time in the process of administering dilute antibiotics. Some powdered antibiotics take a long time to dilute and dissolve the drugs, or are not easy to dissolve. Such drugs often condense into lumps after dilution and mixing. It needs to be shaken for a long time to dissolve completely, resulting in prolonged administration time and increased time for caregivers to wait for complete mixing and dissolution.
目前臨床護理人員平均照護8~12位病患,若有病患使用針劑抗生素藥物種類較多時,可能會導致混合藥物時間延長,或是間接拖延影響其他治療,因此本發明人鑑於上述之需求,深覺習用以人力方式搖晃針 劑以混合粉狀抗生素的方式太過浪費人力及時間,所以遂以其多年從事臨時照護病患的經驗積極研發改良,在各方條件的審慎考量下,終於開創出本結構之組成,將可完全解決習用之各項問題。 Currently, clinical nurses care for an average of 8 to 12 patients. If a patient uses a large number of injectable antibiotics, it may prolong the mixing time of the drugs, or indirectly delay other treatments. Therefore, in view of the above needs, the inventor , deeply aware of the habit of manually shaking the needle The method of mixing powdered antibiotics was too wasteful of manpower and time, so we used our many years of experience in temporary care of patients to actively develop improvements. After careful consideration of all conditions, we finally created this structure, which can Completely solve all the problems of customary use.
本發明係一種針劑藥物之混合器,主要係包括有一內部容置固定馬達的盒體,令該馬達軸心的延伸端部係樞固於盒體一側,且該軸心固定有複數徑向延伸的連接桿經由盒體預設之開槽穿出,並在連接桿末端是固接有可供置入針劑的球型固定盒,令控制電路電性連接的馬達進行反覆旋轉角度之動作,俾以驅使連接桿於開槽的範圍內往復擺動,因此在實施後將可提供下述之效益: The present invention is a mixer for injection drugs. It mainly includes a box body containing a fixed motor inside, so that the extended end of the motor axis is pivoted to one side of the box body, and the axis center is fixed with a plurality of radial The extended connecting rod passes through the preset slot in the box body, and a ball-shaped fixed box for inserting injections is fixed at the end of the connecting rod, allowing the motor that is electrically connected to the control circuit to perform repeated rotation angle movements. In order to drive the connecting rod to swing back and forth within the slotted range, it will provide the following benefits after implementation:
由於本發明的混合器係以具有定時器的控制電路電性連接馬達,且驅使該馬達進行反覆旋轉角度之動作(可採用步進馬達控制其訊號脈波及方向脈波而達成,或以限位開關、接近開關或光電開關達成馬達進行反覆旋轉角度),因此經由馬達軸心固定且徑向延伸的連接桿便可在盒體預設的開槽路徑、範圍內往復擺動,所以放置在球型固定盒內的針劑就會隨著反覆搖擺、晃動之作用力,令針劑在球型固定盒中翻滾、搖晃,以利將針劑內的藥物充分混合均勻。 Because the mixer of the present invention is electrically connected to the motor with a control circuit having a timer, and drives the motor to perform repeated rotation angle actions (this can be achieved by using a stepper motor to control its signal pulse wave and direction pulse wave, or by limiting the position) switch, proximity switch or photoelectric switch to achieve the motor's repeated rotation angle), so the connecting rod fixed by the motor axis and extending radially can swing back and forth within the preset slotted path and range of the box, so it is placed in the ball-shaped The injection in the fixed box will roll and shake in the ball-shaped fixed box with the force of repeated rocking and shaking, so as to fully mix the medicine in the injection evenly.
本發明球型固定盒的內部係設置有緩衝材質,不僅可以保護針劑在翻滾、搖晃過程中的安全性(不會破損),而且可以避免針劑反覆在球型固定盒內搖擺、晃動時發出噪音。再者,以球型固定盒內部的圓型空間供針劑翻滾、搖晃,可讓針劑的晃動過程更為自由,提高藥物混合的效率。 The interior of the ball-shaped fixed box of the present invention is provided with a buffer material, which not only protects the safety of the injection during rolling and shaking (without being damaged), but also prevents the injection from making noise when it repeatedly swings and shakes in the ball-shaped fixed box. . Furthermore, the circular space inside the ball-shaped fixed box is used for rolling and shaking of injections, which can make the shaking process of injections more free and improve the efficiency of drug mixing.
1:盒體 1: Box body
11:開槽 11: Grooving
12:控制電路 12:Control circuit
121:定時器 121: timer
2:馬達 2: Motor
21:軸心 21:Axis
3:連接桿 3: Connecting rod
4:球型固定盒 4: Ball fixed box
41:緩衝材質 41: Buffer material
5:針劑 5:Injection
10:混合器 10:Mixer
〔圖1〕係本創作之結構圖。 [Figure 1] is the structural diagram of this creation.
〔圖2〕係本創作之操作示意圖。 [Figure 2] is a schematic diagram of the operation of this creation.
〔圖3〕係本創作球型固定盒之結構參考圖。 [Figure 3] is a structural reference diagram of the spherical fixed box of this invention.
〔圖4〕係本創作之實施狀態參考圖。 [Figure 4] is a reference diagram of the implementation state of this creation.
〔圖5〕係本創作之針劑翻滾、搖晃示意圖。 [Figure 5] is a schematic diagram of the injection rolling and shaking of this creation.
為使 貴審查人員能確實明瞭本發明之結構組成及其所能達成之功能效益,餘下,茲配合圖式列舉實施例,詳細介紹說明如后: In order to enable the examiner to clearly understand the structural composition of the present invention and the functional benefits it can achieve, the remaining examples are listed in conjunction with the drawings, and the detailed description is as follows:
本發明係一種針劑藥物之混合器,主要係包括有一內部容置固定馬達2的盒體1,令該馬達2軸心21的延伸端部係樞固於盒體1一側(如圖1所示),且該軸心21固定有複數徑向延伸的連接桿3經由盒體1預設之開槽11穿出,並在連接桿3末端是固接有球型固定盒4,令具有定時器121的控制電路12電性連接馬達2進行反覆旋轉角度之動作,俾以驅使連接桿3於開槽11的範圍內往復擺動(如圖2所示),因此置入球型固定盒4的針劑5可以受到反覆搖擺、晃動之作用力,以利將針劑5內的藥物混合均勻。
The present invention is a mixer for injection drugs. It mainly includes a
其中,上述控制電路12電性連接馬達2,且驅使該馬達2進行反覆旋轉角度之動作,係採用習知步進馬達控制其訊號脈波及方向脈波而達成,或以限位開關、接近開關或光電開關達成馬達2進行反覆旋轉角度(圖中未示),因此在本發明的馬達2軸心21係僅具有反覆旋轉角度
(必須小於360度,在本發明中係以小於180度範圍以利於置放在桌面操作,在圖式中係以90度實施)之擺動狀態,所以經由軸心21驅動的複數連接桿3也是隨之在盒體1開槽11的範圍內往復擺動。
Among them, the above-mentioned
而球型固定盒4係以兩半球型殼體對接卡固或樞接設置彈片呈彈力掀蓋式之習知結構(如圖3所示),並於內部設置有緩衝材質41。
The ball-shaped
因此本發明混合器10於實施時,可在球型固定盒4打開後供針劑5置入而閉合,並經由控制電路12控制的馬達2係由定時器121設定其運轉時間(控制電路12包括有一電源/啟動/停止鍵,關機狀態時長按可開啟電源,再次按下則運轉馬達2,運轉中再次按下則停止,開機狀態時長按可關閉電源。而定時器121係預設一時間,可依需求而調整),所以當啟動馬達2帶動連接桿3、球型固定盒4隨之往復擺動時(如圖4所示),球型固定盒4內的針劑5除了可隨著往復擺動的作用力混合藥物之外,針劑5更可在球型固定盒4內自由翻滾、搖晃,提高藥物混合的效率(如圖5所示)。而在此一過程中球型固定盒4的緩衝材質41不僅可以保護針劑5在翻滾、搖晃過程中的安全性(不會破損),更可以避免針劑5反覆在球型固定盒4內搖擺、晃動時發出噪音(不會影響病房的安寧)。
Therefore, when the
基於上述本發明之實施可知,在本發明創作之前並未有針對針劑5的藥物混合提供操作之設備,本發明是首先開創的設計,而且極適合放置在護理工作車上隨時使用,極具有實用價值。
Based on the above-mentioned implementation of the present invention, it can be seen that before the creation of the present invention, there was no equipment for operating the drug mixing of the
1:盒體 1: Box body
11:開槽 11: Grooving
12:控制電路 12:Control circuit
121:定時器 121: timer
2:馬達 2: Motor
21:軸心 21:Axis
3:連接桿 3: Connecting rod
4:球型固定盒 4: Ball fixed box
10:混合器 10:Mixer
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111137450A TWI818754B (en) | 2022-09-29 | 2022-09-29 | Mixer for injection medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111137450A TWI818754B (en) | 2022-09-29 | 2022-09-29 | Mixer for injection medicines |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI818754B true TWI818754B (en) | 2023-10-11 |
TW202412733A TW202412733A (en) | 2024-04-01 |
Family
ID=89857550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111137450A TWI818754B (en) | 2022-09-29 | 2022-09-29 | Mixer for injection medicines |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI818754B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN207970774U (en) * | 2017-12-25 | 2018-10-16 | 郑州舒柯科技有限公司 | A kind of nursing Simple medicament oscillating uniform device |
CN211936655U (en) * | 2019-12-24 | 2020-11-17 | 哈尔滨亿尔诺医学科技有限公司 | Powder medicine mixing device |
CN113274927A (en) * | 2021-06-09 | 2021-08-20 | 南通智宏生物科技有限公司 | Medicine bottle oscillation device based on medical treatment medicament has anti-sedimentation mechanism |
CN113750874A (en) * | 2021-09-07 | 2021-12-07 | 佳木斯大学 | Vibration type powder mixing device for traditional Chinese medicine preparation |
CN215028225U (en) * | 2021-01-13 | 2021-12-07 | 北京肿瘤医院(北京大学肿瘤医院) | Drug dissolution promoting and drug-loaded microsphere mixing shaker |
-
2022
- 2022-09-29 TW TW111137450A patent/TWI818754B/en active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN207970774U (en) * | 2017-12-25 | 2018-10-16 | 郑州舒柯科技有限公司 | A kind of nursing Simple medicament oscillating uniform device |
CN211936655U (en) * | 2019-12-24 | 2020-11-17 | 哈尔滨亿尔诺医学科技有限公司 | Powder medicine mixing device |
CN215028225U (en) * | 2021-01-13 | 2021-12-07 | 北京肿瘤医院(北京大学肿瘤医院) | Drug dissolution promoting and drug-loaded microsphere mixing shaker |
CN113274927A (en) * | 2021-06-09 | 2021-08-20 | 南通智宏生物科技有限公司 | Medicine bottle oscillation device based on medical treatment medicament has anti-sedimentation mechanism |
CN113750874A (en) * | 2021-09-07 | 2021-12-07 | 佳木斯大学 | Vibration type powder mixing device for traditional Chinese medicine preparation |
Also Published As
Publication number | Publication date |
---|---|
TW202412733A (en) | 2024-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Turner et al. | Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation | |
TWI818754B (en) | Mixer for injection medicines | |
Yadav et al. | Animal inflicted maxillofacial injuries: treatment modalities and our experience | |
Rosin et al. | Cefazolin antibacterial activity and concentrations in serum and the surgical wound in dogs | |
PL188153B1 (en) | Drug and manner of exterting a pharmacological effect on human organism by such drug | |
WO1998050045A1 (en) | Improvements in or relating to long-acting antimicrobials | |
CN1990048B (en) | Ultrasonic therapy couplant, its preparing process and packing apparatus | |
CN115554397A (en) | Application of nano piezoelectric material in preparation of in-situ vaccine for resisting bacterial infection | |
CN205964694U (en) | Electronic micropin percutaneous of supersound device of dosing | |
CN104586875A (en) | Preparation method for compound tilmicosin enteric-coated granules | |
CN1206001C (en) | Biodegradable carrier and biodegradable transfer system | |
CN106727351A (en) | Amoxicillin micro-capsule dry suspensoid agent and preparation method thereof | |
Pilny | Use of a compounded Poloxamer 407 antibiotic topical therapy as part of the successful Management of Chronic Ulcerative Dermatitis in a Congo African Grey parrot (Psittacus erithacus) | |
CN101317963B (en) | Traditional Chinese medicine for treating exogenous injury and ulcer and preparation method thereof | |
CN104784311B (en) | Composition of medicine for preventing and treating animal aphtha hoof Huang and preparation method thereof | |
CN108261589A (en) | A kind of microsyringe for acting on lesion target cell | |
Field et al. | Elective Surgery in Hemophilia: I. Correction of Talipes Equinus Deformity | |
Prasad et al. | Management of Burns in Companion Animals: A Report of Three Cases | |
CN103405465A (en) | Preparation method of medicine for treating respiratory system infection of livestock and poultry | |
CN103405463A (en) | Preparation method of synergistic tylosin tartrate soluble powder compound medicine | |
WO2015098864A4 (en) | Gel-forming agent containing sulfonamide and chitosan and having a powdered dosage form | |
CN103405466B (en) | Compound synergistic tylosin tartrate | |
CN106581033A (en) | Compound ceftiofur cream and preparation method thereof | |
Knotek | Therapeutics and medication | |
Lampe et al. | Literature Reviews: Pediatric Pharmacology. |